Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol target-controlled infusion versus intermittent bolus sedation for colonoscopy
RBR-2dxshpRecruiting
- Sponsor
- Hospital de Câncer de Mato Grosso
- Start
- Aug 2017
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of propofol and fentanyl in colonic polyp, diverticular disease, constipation and 1 more (2 arms), sponsored by Hospital de Câncer de Mato Grosso. Primary endpoint: Number of interventions during sedation. Started Aug 2017; status: recruiting.
02
Drugs
propofolfentanyl
03
Conditions
colonic polypdiverticular diseaseconstipationirritable bowel syndrome (IBS)
Beyond the preview
Go deeper on RBR-2dxshp.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-2dxshp.